Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$37.88 - $43.77 $189,172 - $218,587
-4,994 Reduced 15.94%
26,343 $1.13 Million
Q4 2023

Feb 02, 2024

BUY
$31.71 - $38.95 $993,696 - $1.22 Million
31,337 New
31,337 $1.21 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $198,260 - $236,445
4,959 New
4,959 $226,000
Q2 2022

Aug 11, 2022

SELL
$63.83 - $80.0 $4.28 Million - $5.36 Million
-67,021 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $3.92 Million - $4.57 Million
51,035 Added 319.25%
67,021 $5.2 Million
Q4 2021

Jan 28, 2022

BUY
$74.57 - $87.19 $1.19 Million - $1.39 Million
15,986 New
15,986 $1.37 Million
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $1.45 Million - $1.64 Million
-19,606 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$80.5 - $88.01 $1.58 Million - $1.73 Million
19,606 New
19,606 $1.58 Million
Q3 2020

Nov 13, 2020

SELL
$78.33 - $90.73 $580,190 - $672,037
-7,407 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $582,634 - $697,294
7,407 New
7,407 $638,000
Q4 2018

Feb 06, 2019

SELL
$61.45 - $77.8 $16.3 Million - $20.6 Million
-264,920 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$70.71 - $77.75 $18.7 Million - $20.6 Million
264,920 New
264,920 $20.4 Million
Q2 2018

Aug 09, 2018

SELL
$63.43 - $75.41 $17.2 Million - $20.4 Million
-271,025 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$62.56 - $72.26 $17 Million - $19.6 Million
271,025 New
271,025 $17.6 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $19.4 Million - $20.8 Million
-315,528 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$59.5 - $64.61 $18.8 Million - $20.4 Million
315,528
315,528 $19.8 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.